Adamis Pharmaceuticals Corporation Recorded Big Gain
Mon, Jul 20, 2020 at 05:33 PM
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) shot up at $1.07, representing a gain of 39%. On Fri 17 Jul 20, ADMP:NASDAQ touched a New 2-Week High of $0.77. The stock appeared on our News Catalysts scanner on Wed 01 Jul 20 at 09:31 AM in the 'INVESTOR UPDATE' category. From Mon 06 Jul 20, the stock recorded 55.56% Up Days and 40.00% Green Days
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 91.36%
- Majesco (MJCO:NASDAQ), 72.25%
- iBio, Inc. (IBIO:NYSEMKT), 63.94%
- Immuron Limited (IMRN:NASDAQ), 63.42%
- Just Energy Group Inc. (JE:NYSE), 52.46%
- Heat Biologics, Inc. (HTBX:NASDAQ), 47.15%
- Borqs Technologies, Inc. (BRQS:NASDAQ), 44.71%
- DPW Holdings, Inc. (DPW:NYSEMKT), 44.17%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 39.2%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 38.96%